Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05417854 · ClinicalTrials.gov registry record · NA
Ultrasound Treatment for Rheumatoid Arthritis Study [ULTRA Study]
A NA study, sponsored by SecondWave Systems.
- Completed
- Registry status
- NA
- Development phase
- 14
- Enrollment target
NCT05417854 is a NA study that has completed, run by SecondWave Systems. The registered enrollment target is 14 participants.
The verdict
NCT05417854, a NA study, has completed, sponsored by SecondWave Systems.
- COMPLETED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
Study Summary
The research objective is to assess efficacy of spleen ultrasound stimulation in the treatment of rheumatoid arthritis (RA) in a pilot study. Specific Aims: * Measure RA disease activity and clinical metrics during and after an 8-week course of spleen-directed daily ultrasound treatments. * Measure molecular correlates, including Erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), cortisol and cytokine levels, of rheumatoid arthritis disease activity during spleen-directed daily ultrasound treatments.
Interventions
- DEVICE Splenic Ultrasound
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2022-06-29 |
| Est. Completion | 2023-09-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05417854
The ClinicalTrials.gov registry entry for NCT05417854 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is SecondWave Systems, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Splenic Ultrasound is the first listed.
NCT05417854 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05417854 about?
NCT05417854 is a clinical study titled "Ultrasound Treatment for Rheumatoid Arthritis Study [ULTRA Study]". The research objective is to assess efficacy of spleen ultrasound stimulation in the treatment of rheumatoid arthritis (RA) in a pilot study. Specific Aims: * Measure RA disease activity and clinical metrics during and after an 8-week course of spleen-directed daily ultrasound treatments. * Measur...
What is the current status of trial NCT05417854?
This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2022-06-29. Estimated completion is 2023-09-25.
What interventions are being tested in trial NCT05417854?
The interventions under investigation include: Splenic Ultrasound (DEVICE).
Who is sponsoring clinical trial NCT05417854?
This trial is sponsored by SecondWave Systems, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.